Study Maps Somatic Mutations in B Cells of Systemic Lupus Erythematosus Patients, Linking Genetic Changes to Disease Progression
Researchers mapped somatic mutations across B-cell subsets in 35 systemic lupus erythematosus (SLE) patients, finding that double-negative (DN) B cells carry the highest mutational burden. These mutations were associated with disease duration and immunosuppressive therapy rather than disease activity, and occurred in genes also altered in B-cell lymphomas. The findings suggest that chronic immune stimulation and therapeutic pressure drive cancer-like clonal evolution in autoimmune disease, potentially explaining disease progression and heterogeneity.
A preprint study posted to bioRxiv investigated somatic genome diversification as a driver of immune variation in systemic autoimmune rheumatic diseases, using Systemic Lupus Erythematosus (SLE) as a model. The researchers generated a subset-resolved map of somatic mutations across B-cell subsets from 35 SLE patients, revealing that double-negative (DN) B cells accumulate the greatest mutational burden among the subsets examined. Critically, this mutational burden correlated with disease duration and exposure to immunosuppressive therapy rather than with current disease activity levels. Integration with single-cell transcriptomic data linked DN cell mutations to dysregulated signaling pathways and proteostasis — processes involved in protein quality control. Notably, the mutated genes in DN cells overlapped with genes recurrently altered in B-cell lymphomas, raising questions about the relationship between chronic autoimmunity and lymphoma risk. The study provides a molecular resource for understanding how long-term immune activation and treatment shape the clonal landscape of autoimmune B cells. The authors frame somatic genome diversification as a previously underappreciated feature of pathogenic B-cell biology in systemic autoimmunity.
What's missing
As a preprint, this study has not yet undergone peer review. Key limitations and open questions include: whether the observed mutations are causally driving disease progression or are a byproduct of chronic activation; the relatively small sample size (35 patients) and whether findings generalize beyond SLE to other systemic autoimmune diseases; the functional consequences of specific mutations in DN cells remain uncharacterized; and the clinical implications of the lymphoma-associated gene overlap — including whether SLE patients with higher DN mutational burden face elevated lymphoma risk — are not established by this study.
What different sources said
- bioRxivCenter
Somatic Genome Diversification and Clonal Evolution of Pathogenic B Cells in Systemic Autoimmunity
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.